📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Dicerna

1.1 - Company Overview

Dicerna Logo

Dicerna

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology research focused on discovering and developing RNA interference (RNAi)-based treatments for rare inherited liver diseases, cancers, and other liver-related conditions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Dicerna

OPKO Health Logo

OPKO Health

HQ: United States Website
  • Description: Provider of pharmaceuticals and diagnostics based on novel proprietary technologies, including NGENLA, a once-weekly human growth hormone analog for pediatric growth failure due to inadequate endogenous growth hormone secretion, and RAYALDEE, an extended-release oral calcifediol for treating secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and vitamin D insufficiency.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OPKO Health company profile →
NanoString Logo

NanoString

HQ: United States Website
  • Description: Provider of life science tools for basic research, translational medicine, and in vitro diagnostics, offering the CosMx spatial single-cell imaging platform for cell atlasing and biomarker discovery; nCounter data analysis via nSolver and ROSALIND; the nCounter Low RNA Input Kit; a Data Analysis Service; and nCounter panels and assays for gene expression across oncology, neuroscience, and cardiovascular research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NanoString company profile →
SNIPR Biome Logo

SNIPR Biome

HQ: Denmark Website
  • Description: Provider of CRISPR-based microbial gene therapies that selectively target and eliminate hazardous bacteria without harming beneficial microbes; gut-directed gene therapy via engineered bacteria; CRISPR-Guided Vectors (CGV) for rapid, precise bacterial killing; platforms for in situ therapeutic protein and peptide production; backed by an extensive patent portfolio and research collaborations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SNIPR Biome company profile →
Genetron Health Logo

Genetron Health

HQ: China Website
  • Description: Provider of precision medicine solutions: cancer diagnostics and monitoring via genetic mutation detection to guide treatment and track disease; early cancer screening using cfDNA and protein markers, focused on liver cancer; biopharma development services for trial design, companion diagnostics, and target screening; and the GENETRON 3D Biochip Reader, a digital PCR platform for liquid biopsy and genetic testing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genetron Health company profile →
Treos Bio Logo

Treos Bio

HQ: United Kingdom Website
  • Description: Provider of computational immunology solutions that predict in silico likely responders to cancer immunotherapies and design next-generation targeted immunotherapies tailored to patient genetics; offers PolyPEPI1018 for metastatic colorectal cancer (developed without need for tumor biopsy), PEPI Panel to create personalized therapies based on tumor type and HLA genotype, PolyPEPI-SCoV-2 preventive vaccine, and PEPI Test predicting peptide-specific T cell responses.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Treos Bio company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Dicerna

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Dicerna

2.2 - Growth funds investing in similar companies to Dicerna

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Dicerna

4.2 - Public trading comparable groups for Dicerna

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Dicerna

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Dicerna

What does Dicerna do?

Dicerna is a provider of biotechnology research focused on discovering and developing RNA interference (RNAi)-based treatments for rare inherited liver diseases, cancers, and other liver-related conditions.

Who are Dicerna's competitors?

Dicerna's competitors and similar companies include OPKO Health, NanoString, SNIPR Biome, Genetron Health, and Treos Bio.

Where is Dicerna headquartered?

Dicerna is headquartered in United States.

How many employees does Dicerna have?

Dicerna has 1,000 employees 🔒.

When was Dicerna founded?

Dicerna was founded in 2010 🔒.

What sector and industry vertical is Dicerna in?

Dicerna is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Dicerna

Who are the top strategic acquirers in Dicerna's sector and industry

Top strategic M&A buyers and acquirers in Dicerna's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Dicerna?

Top strategic M&A buyers groups and sectors for Dicerna include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Dicerna's sector and industry vertical

Which are the top PE firms investing in Dicerna's sector and industry vertical?

Top PE firms investing in Dicerna's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Dicerna's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Dicerna's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Dicerna's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Dicerna include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Dicerna's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Dicerna?

The key public trading comparables and valuation benchmarks for Dicerna include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Dicerna for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Dicerna with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Dicerna's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Dicerna with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Dicerna's' sector and industry vertical?

Access recent funding rounds and capital raises in Dicerna's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Dicerna